Auspex Pharmaceuticals makes appointments
This article was originally published in Scrip
Executive Summary
Auspex Pharmaceuticals, a US clinical-stage company developing next-generation medicines with improved safety and efficacy, has appointed Michael Grey president and chief executive officer and Gary Gilmore chief financial officer. Mr Grey has more than 30 years' experience in the pharmaceutical and biotechnology industries; he previously served as president and CEO of SGX Pharmaceuticals (which was recently acquired by Lilly). Mr Gilmore was previously CFO of the contract manufacturing organisation Althea Technologies.